Search clinical trials for: HTX-034

Total 3807 results

Meissa Vaccines, Inc.

Recruiting

Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults

Covid19

United States
Ain Shams University

Completed

Mirtazapine vs Sumatriptan in the Treatment of Postdural Puncture Headache

Headache

Egypt
Zhejiang Cancer Hospital

Recruiting

Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Locally Advanced Gastric Cancer

China
Pelican Therapeutics, Inc.

Terminated

PTX-35 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

United States
GTx

Terminated

GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer

Prostate Cancer

United States
Sorrento Therapeutics, Inc.

Withdrawn

Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain

Pain, Intractable | Pain Cancer
Sheba Medical Center

Completed

The Development Of A Novel Biomarker For Early Identification Of The Individual's State Of Tolerance To Heat

Healthy | Heat Stroke

Israel
Genentech, Inc.
Quotient Clinical

Completed

Bioavailability of GDC-0134 and the Effect of Food and Proton Pump Inhibitor on Pharmacokinetics of GDC-0134 in Healthy Female Participants

Amyotrophic Lateral Sclerosis

United Kingdom
Astellas Pharma Europe B.V.

Completed

Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms (Neptune)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Belgium, Italy, France, Austria, United Kingdom, Netherlands, Hungary, Russian Federation, Poland, Slovakia, Czech Republic, Belarus, Germany
Edgewood Oncology Inc.

Recruiting

A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer

Metastatic Breast Cancer | Advanced Solid Tumor

United States
GTx

Terminated

Phase II, Dose Finding Study of GTx-758

Prostate Cancer

United States
Heat Biologics

Withdrawn

A Phase 1 Study of PTX-35 in Healthy Volunteers

Healthy Volunteer
Pharma Holdings AS
University Hospital of North Norway

Completed

LTX-109 as Treatment for Hidradenitis Suppurativa

Hidradenitis Suppurativa

Norway
University of Kansas Medical Center
Kurume University

Completed

Combined Application of Electrical Stimulated Antagonist Contraction During Walking (Walking Study)

Knee Osteoarthritis

United States
NYU Langone Health

Completed

Virtual Reality (VR) to Improve Quality of Life in Patients Diagnosed With Neurological Disorders

Multiple Sclerosis | Chronic Pain | Neurological Disorder

United States
FHI 360
Ministry of Health, Uganda

Completed

Community-based Delivery of Integrated Family Planning/HIV Testing and Counseling Services in Uganda

HIV Testing and Counseling

Uganda
Peking Union Medical College Hospital

Recruiting

68Ga-FAPI-04 PET/CT for the Detection of Oral Carcinoma

Oral Carcinoma

China
Centre Hospitalier Universitaire Dijon

Completed

Evaluate and Understand Preferences and Representations in Families of Patients With Regard to High-throughput Sequencing Technology for Diagnostic Purposes

Rare Diseases

France
Taichung Veterans General Hospital
All Clean Health Co., Ltd

Not yet recruiting

The Effect of AC-134 in Chronic Kidney Diseases

Nephrology

Taiwan
Takeda
Takeda Development Center Americas, Inc.

Not yet recruiting

A First-In-Human Study of TAK-004 in Healthy Adults

Healthy Volunteers
Actelion

Completed

Study of ACT-293987 (NS-304) in Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension

United Kingdom, Austria, Belgium, France, Germany, Hungary, Italy, Poland
Michael Hoelscher
German Federal Ministry of Education and Research; German Center for Infection... and other collaborators

Completed

A Single Ascending Dose Study of BTZ043

Lung Diseases | Bacterial Infections | Mycobacterium Infections | Tuberculosis | Tuberculosis, Pulmonary

Germany
The George Institute
University of Sydney; Fresenius Kabi; Australian and New Zealand Intensive Care...

Completed

Crystalloid Versus Hydroxyethyl Starch Trials (CHEST)

Intensive Care

Australia
Yonsei University

Completed

The Effect of 6% Hydroxyethyl Starch 130/0.4 on Blood Loss and Coagulation in Patients Medicated With Antiplatelet Agents Prior to Off-Pump Coronary Bypass Graft Surgery

Coronary Artery Occlusive Disease

Korea, Republic of
The 923rd Hospital of Joint Logistics Support Force...
Guangzhou Reforgene Medicine Co., Ltd.

Recruiting

Safety and Efficacy of RM-004 Cells for Hemoglobin H-Constant Spring Disease

Hemoglobinopathies | Hereditary Diseases | Alpha Thalassemia Hemoglobin H Constant Spring

China
Abbott Medical Devices

Completed

Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee (BTK) Lesions - A Pilot Study (OPTIMIZE BTK)

Vascular Calcification | PAD

Austria, Germany
Gilead Sciences
Galapagos NV

Withdrawn

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug Therapy (SEALION2-NAÏVE)

Ankylosing Spondylitis
Sunstar Americas

Completed

GUIDOR® Growth Factor Enhanced Bone Graft Substitute for the Treatment of Periodontal Defects 6-months Post-Surgery

Periodontal Diseases | Alveolar Bone Loss

United States
Kolding Sygehus

Unknown

Absorption and Pharmacokinetics of Nitroglycerin to a New Formulation

Angina Pectoris

Denmark
University of Michigan

Completed

Study of the Safety of KSP Heptapeptide (KSP-910638G)

Healthy Adults

United States
Yonsei University

Completed

Respirophasic Carotid Artery Peak Velocity Variation as a Predictor of Fluid Responsiveness in Patients With Coronary Disease

Coronary Artery Occlusive Disease

Korea, Republic of
Theriva Biologics, Inc.
Washington University School of Medicine

Recruiting

SYN-004 Safety and Tolerability in Allo-HCT Subjects

121121000119106, Acute Graft-versus-host Reaction Following Bone Marrow Transplant (Disorder)

United States
INSYS Therapeutics Inc

Completed

Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders

Seizures

United States
Genzyme, a Sanofi Company

Completed

A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea

Antibiotic-Associated Diarrhea | Pseudomembranous Colitis | Clostridium Difficile Diarrhea

Canada
Genzyme, a Sanofi Company

Completed

A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated Diarrhea

Diarrhea | Clostridium Enterocolitis

Australia, Belgium, France, Spain, Germany, Portugal, Switzerland, Austria, United Kingdom, Ireland, Czech Republic, Denmark, Norway, Sweden
IDEA AG

Completed

An Effectiveness and Safety Study of IDEA-033 in Comparison to Oral Naproxen and Placebo for the Treatment of Osteoarthritis of the Knee

Osteoarthritis, Knee

United States
Rigshospitalet, Denmark

Unknown

Fluid Infusion During Breast Surgery

Breast Surgery

Denmark
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study of the Safety, Tolerability, Pharmacokinetics and Pharmcodynamics of ILV-094 in Healthy Subjects

Healthy

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers

Acute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS) | Chronic Myeloid Leukemia (CML)

United States
Morphotek
National Cancer Institute (NCI); Children's Oncology Group

Completed

MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

Unspecified Childhood Solid Tumor, Protocol Specific | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma and other conditions

United States
Azitra Inc.
RCTs

Completed

Safety Study of AZT-04 for Cosmetic Use

Study of Three Doses of AZT-04 for Skin Appearance

United States
Mediar Therapeutics
ICON plc

Recruiting

A First-in-Human Safety Trial of MTX-463

Healthy

United States
University of British Columbia
Fraser Health; Simon Fraser University; Lotte & John Hecht Memorial Foundation

Recruiting

Immersive Multimedia as an Adjunctive Measure for Pain Control in Cancer Patients

Cancer | Chronic Pain

Canada
Geneticure, LLC
University of Minnesota; Fairview Health Services

Not yet recruiting

Investigating the Use of Genetics to Guide Pharmacologic Therapy for Hypertension (PGEN for HTN)

Hypertension

United States
RTI International
Medical Research Council, South Africa

Completed

Cape Town Young Women's Health CoOp

Human Immunodeficiency Virus (HIV) | Condomless Sex | Alcohol and Drug Use | Sexually Transmitted Infections (STIs) | Violence and Victimization | Access and Linkage to Healthcare | Education Advancement

South Africa
Pharma Holdings AS
CTC Clinical Trial Consultants AB

Completed

A Study to Evaluate the Safety and Efficacy of 3% LTX-109 for Nasal Decolonisation of Staphylococcus

Nasal Decolonization of Staphylococcus Aureus

Sweden
Merck KGaA, Darmstadt, Germany

Completed

ATX-MS-1467 in Multiple Sclerosis

Multiple Sclerosis

Germany
Cook Group Incorporated

Terminated

Evaluation of the GTX™ 5126 DES Coronary Stent System in the Treatment of Patients With a Lesion in the Coronary Artery

Coronary Artery Disease

Germany
University of Birmingham
National Institute for Health Research, United Kingdom; University Hospital...

Completed

Pilot Study of Hepatitis C Virus Entry Inhibitor (ITX 5061) in Liver Transplant Recipients (ITX5061)

Hepatitis C | Evidence of Liver Transplantation

United Kingdom
Vivet Therapeutics SAS

Recruiting

A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease (GATEWAY)

Wilson's Disease

United States, Denmark, Germany, United Kingdom

Search clinical trials for: HTX-034

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations